Russell Investments Group Ltd. grew its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 3.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,744,854 shares of the financial services provider’s stock after buying an additional 58,571 shares during the period. Russell Investments Group Ltd. owned 0.27% of MetLife worth $164,536,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Eurizon Capital SGR S.p.A. lifted its position in MetLife by 29.7% during the third quarter. Eurizon Capital SGR S.p.A. now owns 1,337,687 shares of the financial services provider’s stock valued at $126,357,000 after buying an additional 306,277 shares during the period. Werba Rubin Papier Wealth Management purchased a new stake in shares of MetLife in the 3rd quarter worth about $206,000. Maryland State Retirement & Pension System grew its position in shares of MetLife by 14.0% in the 3rd quarter. Maryland State Retirement & Pension System now owns 32,557 shares of the financial services provider’s stock worth $3,066,000 after buying an additional 3,990 shares during the period. Joel Isaacson & Co. LLC increased its stake in shares of MetLife by 2.6% in the 3rd quarter. Joel Isaacson & Co. LLC now owns 16,763 shares of the financial services provider’s stock worth $1,578,000 after acquiring an additional 426 shares in the last quarter. Finally, International Private Wealth Advisors LLC increased its stake in shares of MetLife by 3.1% in the 3rd quarter. International Private Wealth Advisors LLC now owns 4,223 shares of the financial services provider’s stock worth $398,000 after acquiring an additional 126 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.
Insider Buying and Selling
In other MetLife news, CEO Michel Khalaf sold 187,425 shares of the stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total value of $19,299,152.25. Following the transaction, the chief executive officer owned 759,013 shares of the company’s stock, valued at approximately $78,155,568.61. This represents a 19.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.40% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. Keefe, Bruyette & Woods boosted their price target on MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 11th. Evercore reaffirmed a “mixed” rating on shares of MetLife in a research report on Monday, August 24th. TD Cowen raised their price objective on MetLife from $110.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, October 21st. Jefferies Financial Group lifted their price objective on MetLife from $103.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Finally, Weiss Ratings raised MetLife from a “buy (b)” rating to a “buy (b+)” rating in a report on Monday. Fourteen investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $107.12.
Get Our Latest Research Report on MetLife
MetLife Stock Down 1.0%
Shares of MetLife stock opened at $101.87 on Friday. The company has a quick ratio of 0.20, a current ratio of 0.21 and a debt-to-equity ratio of 0.65. MetLife, Inc. has a twelve month low of $67.33 and a twelve month high of $106.72. The company has a market cap of $64.02 billion, a price-to-earnings ratio of 13.28, a price-to-earnings-growth ratio of 0.97 and a beta of 0.79. The company’s 50 day moving average is $98.68 and its 200 day moving average is $86.77.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share for the quarter, beating the consensus estimate of $2.77 by $0.01. The firm had revenue of $20.52 billion for the quarter, compared to analysts’ expectations of $19.86 billion. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The company’s revenue was up 18.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.34 EPS. Research analysts anticipate that MetLife, Inc. will post 9.94 EPS for the current year.
MetLife announced that its board has approved a stock buyback plan on Wednesday, August 5th that allows the company to repurchase $3 billion in outstanding shares. This buyback authorization allows the financial services provider to purchase up to 4.8% of its stock through open market purchases. Share buyback plans are typically a sign that the company’s board believes its shares are undervalued.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be given a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, November 3rd. MetLife’s dividend payout ratio is 30.90%.
MetLife News Roundup
These are some of the MET news items that stood out recently:
- Neutral Sentiment: MetLife was named among the 2026 Fortune World’s Best Workplaces and ranked highly among U.S.-based financial services and insurance companies. The recognition may support its employer reputation, but the article gives no direct financial impact. Fortune workplace recognition article
- Neutral Sentiment: MetLife agreed to divest MetLife UK Limited. The available headline does not specify the terms or expected financial effects, so the impact on the shares is unclear. MetLife UK divestiture article
- Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his direct stake by 19.8%. He still owns 759,013 shares; the sale could nevertheless raise investor concern about insider sentiment. CEO share sale article
About MetLife
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
Further Reading
- Five stocks we like better than MetLife
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
